Boehringer Ingelheim
Boehringer Ingelheim's Overview
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies. Family-owned since its establishment in 1885, the company is committed to creating value through innovation in its three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Boehringer Ingelheim focuses on diseases with high unmet medical need, developing breakthrough therapies that extend and improve lives. With a long-term perspective, sustainability is integral to its strategy, aiming to positively impact health, society, and the planet.
Where is Boehringer Ingelheim's Headquarters?
HQ Function
The global headquarters in Ingelheim serves as the nerve center for Boehringer Ingelheim's worldwide operations, housing key corporate functions, strategic decision-making bodies, and significant research and development activities.
Notable Features:
The Ingelheim campus is an extensive, modern site featuring advanced research laboratories, manufacturing facilities, and administrative buildings. It incorporates green design principles and employee wellness facilities, reflecting a commitment to sustainability and a high-quality work environment.
Work Culture:
The work culture at Boehringer Ingelheim's headquarters is characterized by a strong emphasis on scientific innovation, collaboration across diverse teams, and a patient-centric approach. As a family-owned company, there's a focus on long-term stability, employee development, and a respectful, inclusive environment.
HQ Significance:
The Ingelheim headquarters is historically and strategically paramount. It is the founding location of the company and continues to drive global strategy, research breakthroughs, and corporate governance for all its international operations.
Values Reflected in HQ: The headquarters design and operations reflect core company values such as innovation (through cutting-edge R&D centers), responsibility (environmental sustainability initiatives and community engagement), and respect (employee-focused amenities and collaborative workspaces).
Location:
Boehringer Ingelheim maintains a robust global presence, operating in over 100 countries across all continents. Key functions supported globally include a worldwide network of research and development centers focused on discovering new treatments; numerous manufacturing sites ensuring the supply of high-quality pharmaceuticals and animal health products; and extensive sales, marketing, and distribution networks tailored to meet the needs of patients, healthcare professionals, and animal owners in diverse markets. The company also conducts clinical trials on an international scale to develop and register new medicines.
Street Address:
Binger Strasse 173
City:
Ingelheim am Rhein
State/Province:
Rhineland-Palatinate
Country:
Germany
Boehringer Ingelheim's Global Presence
Ridgefield, Connecticut, USA
Address: 900 Ridgebury Road, Ridgefield, CT 06877, USA
Serves as the primary center for Boehringer Ingelheim's activities in its largest market, driving innovation, clinical trials, and market access for new therapies in the United States.
Biberach an der Riss, Germany
Address: Birkendorfer Strasse 65, 88397 Biberach an der Riss, Germany
Functions as a key European R&D and manufacturing hub, particularly for complex biologics, supporting the global supply chain and driving advancements in biopharmaceutical technology.
Shanghai, China
Address: 10F, BEA Finance Tower, No.66 Hua Yuan Shi Qiao Road, Pudong, Shanghai 200120, P.R. China
Drives the company's strategy and growth in Greater China, focusing on bringing innovative medicines to Chinese patients and animals, and fostering local R&D collaborations.
Vienna, Austria
Address: Dr.-Boehringer-Gasse 5-11, 1120 Vienna, Austria
Acts as a major European hub for oncology research and biopharmaceutical innovation, contributing significantly to Boehringer Ingelheim's global R&D pipeline.
Buying Intent Signals for Boehringer Ingelheim
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Boehringer Ingelheim
As of April 2025, Boehringer Ingelheim' leadership includes:
Investors of Boehringer Ingelheim
Boehringer Ingelheim has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past 12 months, a key change in Boehringer Ingelheim's Board of Managing Directors involved the retirement of Jean Scheftsik de Szolnok and the appointment of Shweta G S as the new Head of Animal Health.
Departures
New Appointments:
Technology (Tech Stack) used by Boehringer Ingelheim
Discover the tools Boehringer Ingelheim uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Boehringer Ingelheim Email Formats and Examples
Boehringer Ingelheim primarily utilizes a standardized email format for its employees globally, which is firstname.lastname@boehringer-ingelheim.com. This structure promotes consistency and ease of communication. While minor variations might exist for specific departments or countries, this is the most common format.
firstname.lastname@boehringer-ingelheim.com
Format
john.doe@boehringer-ingelheim.com
Example
92%
Success rate
News and media
Boehringer Ingelheim Press Release • June 18, 2024
Boehringer Ingelheim and Covantex to Develop Novel Therapies for Chronic Liver Diseases
Boehringer Ingelheim and Covantex announced a research collaboration to develop novel therapies for chronic liver diseases such as Metabolic Dysfunction-Associated Steatohepatitis (MASH). The partnership will leverage Covantex’s unique single-cell analytics platform....more
Boehringer Ingelheim US Press Release • May 20, 2024
Boehringer Ingelheim's OFEV® (nintedanib) Receives FDA Approval for Children and Adolescents with Chronic Fibrosing Interstitial Lung Disease with a Progressive Phenotype
The U.S. Food and Drug Administration (FDA) has approved OFEV® (nintedanib) oral capsules for the treatment of chronic fibrosing interstitial lung disease with a progressive phenotype (PF-ILD) in children and adolescents aged 6 to 17 years, making it the first approved treatment for PF-ILD in this age group in the U.S....more
Boehringer Ingelheim Press Release • April 17, 2024
Boehringer Ingelheim Reports Strong Growth in 2023, Advancing Pipeline and Expanding Access to Medicines
Boehringer Ingelheim announced strong business performance in 2023. Group net sales rose by 9.7% in currency-adjusted terms to 25.6 billion EUR, driven by high demand for innovative products for both Human Pharma (10.3% growth) and Animal Health (6.9% growth). R&D investments increased by 14.2% to 5.8 billion EUR....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Boehringer Ingelheim, are just a search away.